Indeed, while rapamycin and its derivatives detrimentally affect lipid and glucose homeostasis20, we have previously demonstrated that PRAS40 gene therapy with adenoviral vectors improves hepatic insulin sensitivity and reduces systemic hyperglycemia and hyperlipidemia in obese mice24. This evidence concerns the gene AKT1S1 and hyperlipidemia.